학술논문
HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency
Document Type
Short Communication
Author
Source
In The Journal of Allergy and Clinical Immunology August 2020 146(2):447-450
Subject
Language
ISSN
0091-6749